Acadia Q3 top line up 7%, ytd cash flow ops up 121%

• Acadia Healthcare (NASDAQ:ACHC) Q3 results:
• Revenue: $833.3M (+7.2%).
• Net income: $37.0M (-13.1%); non-GAAP net income: $60.3M (+31.1%); EPS: $0.42 (-12.5%); non-GAAP EPS: $0.68 (+30.8%).
• Non-GAAP EBITDA: $159.4M (+8.7%).
• Cash flow ops (9 mo.): $472.2M (+121.2%).
• Q4 guidance: Revenue: $810M - 835M; non-GAAP EPS: $0.68 - 0.72; non-GAAP EBITDA: $160M - 165M.
• Same facility revenue up 7.5%.
• 100 beds added to U.S. business.
• On another note, an institutional shareholder is suing the board claiming that it fraudulently concealed the "gruesome" and "devastating" effects of relentless cost-cutting on patients while making more than $1B in insider stock trades.
• https://seekingalpha.com/news/3629021-acadia-q3-top-line-up-7-ytd-cash-flow-ops-up-121